Skip to main content
. 2022 Feb 12;76:103836. doi: 10.1016/j.ebiom.2022.103836

Figure 1.

Fig 1

Phosphorylated tau CSF epitopes by group. Distribution of CSF biomarkers concentrations across groups showing higher biomarker levels associated with Aβ positivity. CU-: cognitively unimpaired Aβ negative; CU+: cognitively unimpaired Aβ positive; CI-: cognitively impaired Aβ negative; CI+: cognitively impaired Aβ positive; MCI+: mild cognitively impaired Aβ positive; AD: Alzheimer's disease dementia; Non-AD: mild cognitively impaired Aβ negative and frontotemporal dementia (FTD). ⁎⁎⁎P<0.001; ⁎⁎P<0.01; *P<0.05 (Tukey HSD adjusted).